📖
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database.
Jacot W, Macouillard P, Zhang S, Byng D, Hunter S, Massard V, Frenel JS, Pérol D, Brain E, Mailliez A, Bachelot T, Arnedos M, Bosquet L, Diéras V

Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Breast.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database.
Author / Organization Jacot W, Macouillard P, Zhang S, Byng D, Hunter S, Massard V, Frenel JS, Pérol D, Brain E, Mailliez A, Bachelot T, Arnedos M, Bosquet L, Diéras V
Subject & Discipline Breast
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-14450
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »